Effects of vitamin K2 administration in the patients with severely motor and intellectual disabilities: Assessment of bone metabolic marker and bone mineral density

No To Hattatsu

Volumn 32, Issue 6, 2000, Pages 491-496

  Tanaka, Y ^a   Shibata, R ^a  

^a Natl Minamifukuoka Chest Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; DEOXYPYRIDINOLINE; MENATETRENONE; OSTEOCALCIN; PYRIDINOLINE; VITAMIN K GROUP; BIOLOGICAL MARKER; DRUG DERIVATIVE; FARNOQUINONE;

ARTICLE; BONE DENSITY; BONE MINERAL; DENSITOMETRY; DRUG EFFECT; HUMAN; MOTOR DYSFUNCTION; SIDE EFFECT; URINARY EXCRETION; ADULT; BLOOD; BONE; BONE DEVELOPMENT; DISABLED PERSON; FEMALE; HOSPITALIZATION; MALE; METABOLISM; OSTEOLYSIS; PHYSIOLOGY; RADIODENSITOMETRY;

ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; DENSITOMETRY, X-RAY; DISABLED PERSONS; FEMALE; HUMANS; MALE; OSTEOCALCIN; OSTEOGENESIS; SEVERITY OF ILLNESS INDEX; VITAMIN K; VITAMIN K 2;

EID: 0033623577     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. 3- induced mineralization in human periosteal osteoblast
2. 2 synthesis in vivo
3. Menatetrenone ameliorates osteopenia in diffuse-affected limbs of vitamin D- and K-deficient stroke patients
4. Phylloquinone transport and its influence on gamma-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis
5. Association of bone mineral density with apolipoprotein E phenotype